Comparison of methods for determining zeta‐chain associated protein – 70 (ZAP‐70) expression in patients with B‐cell chronic lymphocytic leukemia (B‐CLL)
Open Access
- 15 July 2006
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 70B (4) , 293-301
- https://doi.org/10.1002/cyto.b.20133
Abstract
Background: Zeta‐chain associated protein of 70kDa (ZAP‐70) is the most promising surrogate marker for the immunoglobulin heavy chain variable region (IgVH) mutation status in B‐cell chronic lymphocytic leukemia (B‐CLL). Crespo et al. proposed the detection of ZAP‐70 by flow cytometry. Recently several novel monoclonal antibodies appeared on market.Methods: We compared different staining methods utilizing monoclonal antibodies (moAb) against ZAP‐70: anti‐ZAP‐70 PE, clone 1E7.2, anti‐ZAP‐70 PE, clone 17A/P‐ZAP70 directly stained with flourochrome as well as anti‐ZAP‐70 antibody, clone 2F3.2 stained with Zenon™ Alexa Fluor® 488 Labeling Kit. Additionally different reagents for permeabilization such as IntraPrep, FIX & PERM, Perm/Wash and 70% ethanol/paraformaldehyde were used to find the most clinically relevant and easy assay to determine ZAP‐70 expression in B‐CLL. Moreover we compared results of ZAP‐70 expression assessed by whole blood protocol with those obtained using‐peripheral mononuclear cells isolated from whole blood.Results: Anti‐ZAP‐70 moAb clone 17A/P‐ZAP70 gave elevated results for all B‐CLL patients as well as healthy controls. Staining with anti‐ZAP‐70 moAb clone 1E7.2 and anti‐ZAP‐70 moAb clone 2F3.2 was effective in distinguishing negative and positive cells for ZAP‐70 protein expression. Not statistically significant discrepancies of ZAP‐70 expression were noticed between different fixation and permeabilization methods.Conclusion: Basing on results obtained during this study we can recommend use of anti‐ZAP‐70 PE, clone 1E7.2 moAb utilizing whole blood protocol with commercial kits for permeabilization as an easy method that brings compatible results to the original method proposed by Crespo et al. © 2006 International Society for Analytical CytologyKeywords
This publication has 23 references indexed in Scilit:
- Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaEmerging Therapeutic Targets, 2005
- Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratoryClinical and Laboratory Haematology, 2005
- Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemiaLeukemia, 2005
- CLL Biology and PrognosisHematology-American Society Hematology Education Program, 2005
- ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2004
- NF-?B inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: Difficulties in identification of dead cells in such culturesCytometry, 2003
- Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemiaBlood, 2002
- Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now?The Hematology Journal, 2002
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chainCell, 1992